Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANCE Trial: Intracoronary ADRCs in STEMI
2010-022153-42Phase 2Terminated
- Sponsor
- Cytori Therapeutics, Inc
- Start
- Aug 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of autologous adipose-derived stem/stromal cells in myocardial infarction (MI), sponsored by Cytori Therapeutics, Inc. Primary endpoint: Primary efficacy endpoint: change in infarct size at 6 months. Started Aug 2010; status: terminated.
02
Drugs
autologous adipose-derived stem/stromal cells
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2010-022153-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022153-42.